Actively Recruiting

Phase 1
Age: 18Years - 64Years
All Genders
NCT07508020

A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity

Led by Novo Nordisk A/S · Updated on 2026-04-27

120

Participants Needed

1

Research Sites

94 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this clinical study is to look at if/how much NNC0487-0111 affects food intake, appetite and metabolism in participants with obesity when compared to placebo. There are 2 study treatments in this study. Participants will inject the study treatment under the skin of your stomach once a week. Participants will get either NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants will get is decided by chance.

CONDITIONS

Official Title

A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity

Who Can Participate

Age: 18Years - 64Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female (sex at birth)
  • Age 18-64 years at time of informed consent
  • Eligible based on medical history, physical exam, vital signs, ECG, and lab tests
  • Overweight due to excess body fat as judged by investigator
Not Eligible

You will not qualify if you...

  • Female who is pregnant, breastfeeding, or planning pregnancy without adequate contraception
  • History of type 1 or type 2 diabetes mellitus
  • Glycated hemoglobin (HbA1c) 6.5% or higher at screening
  • Prior use or intolerance of incretin or amylin-based therapies
  • Significant body weight change (5% or more) or dieting attempts within 90 days before screening
  • Presence or history of significant respiratory, metabolic, renal, liver, heart, gastrointestinal, or endocrine conditions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Parexel International GmbH

Berlin, Germany, 14050

Actively Recruiting

Loading map...

Research Team

N

Novo Nordisk

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here